Anuh Pharma soars on getting approval from COFEPRIS for three of its Erythromycin products

Anuh Pharma is currently trading at Rs. 163.40, up by 11.60 points or 7.64% from its previous closing of Rs. 151.80 on the BSE. The scrip opened at Rs. 151.40 and has touched a high and low of Rs. 165.00 and Rs. 151.40 respectively. So far 14130 shares were traded on the counter. The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 168.80 on 25-Feb-2014 and a 52 week low of Rs. 105.00 on 13-Aug-2013. Last one week high and low of the scrip stood at Rs. 165.00 and Rs. 146.00 respectively. The current market cap of the company is Rs. 128.20 crore. The promoters holding in the company stood at 65.00% while Non-Institutions held 35.00% stake in the company. Anuh Pharma has received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of its Erythromycin products. These three products are Erythromycin Estolate, Erythromycin Ethyl Succinate and Erythromycin Stearate. Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.